Brucella test significance
| Parameter | Detail |
|---|---|
| Antigen used | Smooth B. abortus antigen (heat-killed, phenolized) |
| Species detected | B. abortus, B. suis, B. melitensis |
| Species NOT detected | B. canis, B. ovis, B. abortus strain RB51 |
| Significant titer (nonendemic area) | ≥1:160 |
| Significant titer (endemic area) | ≥1:320-1:640 |
| Significant rise | Fourfold or greater rise between acute and convalescent specimens (≥2 weeks apart) |
| IgG agglutinin titer indicating active infection | >1:80 (Jawetz) |
| Finding | Interpretation |
|---|---|
| SAT positive, 2-ME positive | Active disease (IgG present) - acute or chronic infection |
| SAT positive, 2-ME negative | Old/past infection (only IgM remains, IgG absent) |
| Both negative | No active infection |
| Clinical Scenario | Preferred Test(s) |
|---|---|
| Acute brucellosis | Blood culture + SAT |
| Acute, culture-negative | SAT (titer ≥1:160 nonendemic, ≥1:320 endemic) |
| Acute vs. past infection | 2-ME test (IgG vs. IgM differentiation) |
| Chronic brucellosis (SAT negative) | Coombs test + ELISA |
| B. canis suspected | B. canis-specific antigen-based serology |
| Cure assessment | Cannot use PCR; rely on clinical + SAT trends |
| Monitoring after treatment | SAT titres (may remain positive >2 years) |